International Atomic Energy Agency
Department of Nuclear Sciences and Applications
IAEA-WCI-KAERI
Training Course on
Diagnostic
and Therapeutic Radioisotopes and Radiopharmaceuticals Application
Prospectus
Title: |
Diagnostic and Therapeutic Radioisotopes and Radiopharmaceuticals
Application |
|
Host Institutes: |
World Council on Isotopes (WCI) Korea Atomic Energy Research Institute (KAERI) |
|
Date: |
10 (Monday) – 20 (Thursday) July 2017 |
|
Deadline for Nominations: |
12 June 2017 |
|
Organizers: |
The International Atomic Energy Agency (IAEA) in cooperation with the World
Council on Isotopes (WCI) and Korea Atomic Energy Research Institute (KAERI) |
|
Host Country Organizer: |
Mr. Woo-Geun SONG Director Secretariat World Council on Isotopes (WCI) Tel: +82-2-3490-7150 E-mail: Secretary@wci-ici.org |
Mr. Hyeon-Jin KIM Senior Researcher Nuclear Training & Education Center Korea Atomic Energy Research Institute (KAERI) Tel: +82-42-868-2667 E-mail: Hj_kim@kaeri.re.kr |
Language: |
English |
|
Objective: |
The objective of this training course is to strengthen the transfer of
crucial knowledge and practical skills to technical professionals in the
radiopharmaceutical field, so they can build the leadership skills needed to
manage radioisotopes and radiopharmaceuticals for diagnostic and therapeutic
applications in their home countries. |
|
Scope and Nature: |
The course will take place over two weeks, providing lectures,
discussions, practical exercises, and scientific visits. The program will
cover the following.
Lectures and
discussions -
Module 1: Radiochemistry -
Module 2: Radioisotopes -
Module 3:
Radiopharmaceuticals
Practical
exercises and scientific visits -
Module 1:
Reactor and cyclotron facilities -
Module 2:
Radiopharmaceutical production facilities that obtained Good Manufacturing
Practice (GMP) accreditations for therapeutic radiopharmaceuticals -
Module 3:
Hospitals that are involved in radioisotope and radiopharmaceutical use for
diagnostic and therapeutic applications |
|
Participants’ Qualifications and Experience: |
Participants should be qualified or experienced in the following.
Proficient in
English with good listening comprehension and communication skills in order
to actively participate in the training course without difficulty.
Staff at
R&D or medical institutions in the radiochemistry or radiopharmaceutical
field. However, medical technologists who operate radiological instruments
are excluded.
Possess at
least a scientific or technical bachelor’s degree.
Priority will be given to the following participants.
Those in
charge of producing, manufacturing, and quality management of
radiopharmaceuticals from radiopharmaceutical manufacturers.
Those working
in the field of radiolabeling and quality control in R&D institutions or
hospitals.
Those possessing
scientific or technical degrees higher than a bachelor’s degree in the
radiochemistry or radiopharmaceutical field.
Those in
charge of approval or authorisation in the radiopharmaceutical field.
Those conducting
tasks for fluorodeoxyglucose (FDG) production. |
|
Application Procedure: |
Applications should be submitted to the secretariat of the World
Council on Isotopes. Nominations should include the applicant’s name; birth
date and place; nationality; education and experience; occupation and
employer's address; and passport number and expiration date. They must be
received by the World Council on Isotopes (Secretary@wci-ici.org) no later than 12 June 2017. A selection committee
will evaluate the applications, and applicants will be notified of its
decision by email. |
|
Administrative and Financial Arrangements: |
The World Council on Isotopes will give a limited number of grants to
non-local participants from developing countries. Selected participants will
be provided with round-trip economy class airfare from their home countries
to Seoul, Korea, and a stipend covering the cost of their accommodation,
food, and minor incidentals. The organizers of the course do not accept
liability for the payment of any cost or compensation that may arise from
damage to or loss of personal property or from illness, injury, disability,
or death of a participant while he/she is travelling to and from or attending
the course, and it is clearly understood that each organization, in
nominating participants, undertakes responsibility for such coverage.
Organizations are well advised to take out insurance against these risks. A
copy of the insurance policy will be requested for the issuance of the visa. |